Podcasts about psychedelics today

Holotropic Breathwork sits at the center of this wide ranging conversation between Psychedelics Today co-founders Joe Moore and Kyle Buller. Drawing from decades of personal practice and assorted types of breathwork facilitation, they explore how breathwork methods from the Grof lineage including Dreamshadow Breathwork can prepare people for psychedelic work, support difficult journeys, and deepen integration over time. Kyle shares how his near death experience, somatic training, and breathwork facilitation shaped this new course on breathwork foundations, while Joe reflects on how reading Dr Stanislav Grof and years of experience in Holotropic Breathwork changed how he approaches psychedelics. Early Themes: Roots, Lineages, and First Encounters The episode opens with how each of them first found breathwork. Joe discovered Grof's writing in college, then traveled to Dreamshadow workshops long before he worked seriously with psychedelics. Kyle came to Holotropic style breathwork while studying transpersonal psychology at Burlington College, arriving as a skeptic who assumed people were exaggerating until his first session opened into a full psychedelic level process. They trace the roots of breathwork in modern psychology back to Wilhelm Reich, character armor, and early somatic approaches, then follow that thread into Grof's work and later branches. Joe and Kyle map out the different schools that emerged, including Grof Transpersonal Training, Grof Legacy Training, and Dreamshadow, and explain why the term "breathwork" has become a huge umbrella that covers everything from Wim Hof to short online sessions that are not actually Holotropic Breathwork. Core Insights: Breath, Nervous System, and Working the Edges In the middle of the episode they move into what this new foundations course actually covers and why it matters now. Rather than promising quick fixes, Kyle frames breath as a flexible tool for: Preparation before psychedelic sessions Navigation during intense or destabilizing moments Integration and nervous system support afterward They discuss window of tolerance, fight flight freeze responses, and how fast, deep breathing can open powerful experiences but also risk overwhelm if there is no somatic literacy. Kyle shares a vivid story from a ketamine training where his near death trauma was reactivated and how simple breath awareness, slow belly breathing, and body based skills kept him from panicking or fleeing. Throughout, they return to a key point: Holotropic Breathwork and related practices can restore agency. The breather chooses when to intensify, when to slow down, and how far to go, which can be deeply reparative for people whose trauma involved a loss of control. Later Discussion and Takeaways: Holotropic Breathwork as Foundation, Not Shortcut Later in the conversation, Joe and Kyle caution against "keeping up with the Joneses" in psychedelic culture. They talk about people chasing ever bigger doses, accruing trauma, and then needing years of therapy to sort it out. Breathwork, including Holotropic Breathwork in a well held group setting, is offered as a slower, more grounded way to explore non ordinary states while building skills that transfer into medicine work. They outline the core components of Grof lineage breathwork: intensified breathing, evocative music, focused body support, expressive art, and group sharing in a safe container. Joe highlights how group process, mandala drawing, and simply being witnessed can be as healing as the inner journey itself. They also flag practical next steps: Kyle's self paced breathwork foundations course at the Psychedelic Education Center, upcoming live online sessions, and in person weekend workshops in places like Breckenridge. Frequently Asked Questions What is Holotropic Breathwork? Holotropic Breathwork is a structured group process developed by Stan and Christina Grof that uses accelerated breathing, evocative music, supportive bodywork, art, and integration sharing to access non ordinary states of consciousness without substances. Is Holotropic Breathwork as intense as psychedelics? For some people, yes. Joe and Kyle both describe Holotropic Breathwork sessions that matched the depth of powerful LSD or ayahuasca journeys, while also noting that some sessions are quiet, restful, and focused on simple nervous system regulation. Can I do Holotropic Breathwork alone at home? They strongly suggest caution. Gentle breath practices can be explored solo, but Holotropic Breathwork as taught in the Grof lineages is designed for a trained facilitation team and a group container to reduce risk and support intense emotional or somatic processes. How does Holotropic Breathwork help with psychedelic preparation and integration? Breathwork helps people learn their own nervous system, practice staying with difficult material, and build trust in inner process. These skills often translate into more resilience, flexibility, and agency before, during, and after psychedelic sessions. Is Holotropic Breathwork backed by research? Research on breathwork is growing, especially around heart rate variability, stress, and subjective mystical type experiences. Joe and Kyle emphasize that early studies suggest overlaps with psychedelic states, but they avoid framing Holotropic Breathwork as a cure and instead present it as a powerful tool within a broader healing path. In a culture that often treats psychedelics like quick fixes, this episode makes the case for slow foundations, embodied practice, and honest respect for the risks. By placing Holotropic Breathwork and the other Grof lineage breathwork practices inside a larger conversation about trauma, agency, and community, Joe and Kyle offer a grounded path for anyone who wants to explore non ordinary states in a safer, more skillful way. Learn more about breathwork in the Foundations class here.

Alexander Beiner joins Psychedelics Today to explore how psychedelics, culture, and power shape each other. A writer, facilitator, and co founder of the conference Breaking Convention and the media platform KAINOS, he has spent years thinking about how psychedelic experiences ripple into politics, economics, conflict, and community. In this episode, he and Joe trace the path from early internet forums to today's psychedelic renaissance, and ask what it would mean to bring a truly psychedelic perspective into our institutions. Beiner is less interested in psychedelics as a niche medical tool and more interested in how they can help us see through destructive cultural "games," reconnect to our bodies, and relate across deep divides. Early themes with Alexander Beiner The conversation starts with Beiner's origin story. He describes formative psychedelic experiences as a teenager, and how early access to thinkers like Terence McKenna, Timothy Leary, and the Shulgins led him onto the Grow Report forum and its associated podcasts. From there he launched his own visionary art podcast and eventually co founded Rebel Wisdom, where he focused more broadly on culture, systems, and meaning rather than only on psychedelics. He explains that most of his writing has not been about psychedelic substances, but about a "psychedelic approach" to reality. That means paying attention to complexity, paradox, and relationship, and asking what a psychedelic form of education, politics, or media might look like. He also touches on his documentary "Leviathan," which looks at breakdowns of trust, disembodiment, and the social forces that pull us away from what is real and relational. Core insights from this conversation In the middle of the episode, the discussion moves into concrete tensions in the current psychedelic resurgence. Topics include: How medicalization can both help and constrain access Cognitive liberty and the right to alter one's own consciousness Psychedelic capitalism and the "Moloch" problem of destructive competitive games The risks and potential of psychedelic religions and new spiritual communities Beiner highlights work on ayahuasca circles for Israelis and Palestinians, noting how "we are all one" language can sometimes block necessary truth telling about power and harm. He returns often to embodiment as a key corrective. When people slow down, feel their bodies, and notice what is actually happening in their nervous systems, they can hold disagreement without dehumanizing each other. He also points to emerging work on psychedelics for creativity and problem solving, including stories where psychedelic insights contributed to breakthroughs in science and complex systems thinking. For him, this is one of the most exciting frontiers, because it shifts the story from "fixing a deficit" to "creating something new." Later discussion and takeaways with Alexander Beiner Later in the episode, Alexander Beiner and Joe talk about cult dynamics, religious freedom, and the need for better checks and balances in emerging psychedelic communities. Beiner stresses that humans are naturally drawn into strong groups and narratives, so the key is not to eliminate "cults" but to spot harmful patterns early and build better accountability. They explore how double binds and mixed messages can create mental distress, and how psychedelics can sometimes resolve these binds by adding new context and perspectives. From there, the conversation turns to third spaces, communitas, and the urgent need for more embodied, in person culture beyond screens, work, and home. Practical takeaways include: Work with psychedelics in ways that reconnect you to your body, not just your ideas Treat medicalization as one path among many, not the only legitimate route Pay attention to group dynamics, power, and accountability in any psychedelic setting Look for ways to bring "psychedelic virtues" like flexibility, curiosity, and compassion into your workplace, family, and community Frequently Asked Questions Who is Alexander Beiner? Alexander Beiner is a writer, facilitator, and co founder of the psychedelic conference Breaking Convention and the media platform Kinos. His work focuses on culture, systems, and how psychedelic perspectives can reshape society. What is Alexander Beiner's book about? His recent book (discussed in this episode) looks at how psychedelics interact with politics, capitalism, and culture, and asks whether they can help us navigate multiple crises without getting captured by the same destructive games. How does Alexander Beiner view psychedelic medicalization? He sees medicalization as useful but limited. He supports access for people who need it, but worries that a purely medical frame reinforces class divides and hands too much power to psychiatry, instead of centering cognitive liberty and community based use. What is Leviathan in Alexander Beiner's work? "Leviathan" is his documentary on the breakdown of trust, disembodiment, and large scale systems that pull us away from what is real and relational. It connects mythic images, embodiment, and modern crises of meaning. What is Kinos and how does it relate to Alexander Beiner? KAINOS is Beiner's Substack based media platform, focused on surfacing novel perspectives and stories about culture, psychedelics, and the future. It extends many of the themes explored in this episode. This episode places Alexander Beiner within the wider psychedelic resurgence as a voice linking inner work to outer systems. For clinicians, researchers, and community members, it offers a rich invitation to think beyond individual healing and ask how psychedelic perspectives might help us transform the cultural games we are playing. KAINOS The Bigger Picture Breaking Convention

Overview Evelyn Eddy Shoop PMHNP-BC joins Psychedelics Today to share her journey from Division I athlete to psychiatric mental health nurse practitioner and psilocybin research participant. In this conversation, she explains how sports injuries, OCD, and intensive treatment led her into psychiatry and eventually into a psilocybin clinical trial at Yale. Her story weaves together lived experience, clinical training, and a call for more humane systems of care and better qualitative data in psychedelic science. Early Themes: Injury, OCD, and Choosing Psychiatry Early in the episode, Evelyn Eddy Shoop PMHNP-BC describes how multiple season ending injuries in college and serious mental health stressors in her family pushed her to rethink her life path. Originally pre vet, she stepped away from veterinary medicine after realizing she could not tolerate that environment. During a semester off for surgery and mental health, she completed intensive outpatient treatment and family therapy. That time showed her how powerful psychological work could be. It also reawakened a long standing curiosity about the brain, consciousness, and human experience. This led her to switch her major to psychology and later pursue psychiatric mental health nurse practitioner training at the University of Pennsylvania. At Penn, she felt supported academically and personally. Her interest in psychedelics grew as she realized that standard OCD treatments and high dose SSRIs were not giving her the level of functioning or happiness she knew was possible. Core Insights: Psilocybin Trials, Qualitative Data, and Clinical Skepticism In the middle of the episode, Eddy shares the story of finding a psilocybin trial on ClinicalTrials.gov just as she was about to start ketamine therapy. She received placebo first, then open label psilocybin, and describes the dosing day as one of the hardest days of her life, with benefits that emerged slowly over months through integration. She uses her experience to highlight why qualitative data matters. Numbers alone cannot capture the depth of a psychedelic journey or the slow unfolding of meaning over time. She argues that subjective stories, even difficult ones, are essential for clinicians, researchers, and policymakers. Key themes include: The central role of integration support in turning a crisis level session into lasting growth How trial environments on inpatient psychiatric units can feel like prison instead of healing spaces The limits of double blind placebo trials when participants become desperate for active treatment The need for more nuanced language around psychosis and psychedelic harms Eddy also addresses skepticism in psychiatry. Many providers fear substance induced psychosis and feel uneasy with medicines whose mechanisms are not fully understood. She suggests that more lived experience stories and careful education can help bridge that gap. Later Discussion and Takeaways In the later part of the episode, Eddy and Joe discuss harm reduction, ketamine risks, and how poorly designed systems can create harm even when the medicine itself is helpful. Eddy describes being treated as "just another psych patient" once the research team left for the day, including being denied basic comforts like headache relief after an emotionally intense session. She calls for: More humane hospital and research environments Required psychedelic education in psychiatric training Honest, nonjudgmental conversations about substance use with patients Stronger public education for students and festival communities Eddy also invites listeners in Wilmington, Delaware and nearby regions to connect if they need a psychiatric mental health nurse practitioner for psychedelic related research. She hopes to bring her lived experience and clinical skills into the emerging field as psilocybin and other treatments move toward approval. Frequently Asked Questions Who is Evelyn Eddy Shoop PMHNP-BC? She is a psychiatric mental health nurse practitioner trained at the University of Pennsylvania, a former Division I athlete, and a psilocybin trial participant who now advocates for more humane and data informed psychedelic care. What did Eddy learn from her psilocybin clinical trial experience? She learned that the hardest sessions can lead to deep change when integration support is strong and when there is time to unpack insights, rather than rushing to rate symptoms on a scale. Why does she care so much about qualitative data in psychedelic research? Eddy believes that numbers cannot capture the full human impact of psychedelic therapy. Stories show how people actually live with their disorders and integrate change, which is vital for ethical practice and policy. How does she view psychedelic harms and psychosis risk? She acknowledges real risks, especially for people with certain histories, but also notes that some psychotic experiences are not distressing. She calls for more precise language, better containers, and honest harm reduction education. What role does a psychiatric nurse practitioner like Evelyn play in psychedelic care? Practitioners like Evelyn can assess risk, prescribe within legal frameworks, provide preparation and integration, and help bridge the gap between traditional psychiatry and emerging psychedelic therapies. Psychedelic care is evolving fast, and this episode shows why voices like Evelyn Eddy Shoop PMHNP-BC are essential in the current psychedelic resurgence. Her blend of lived experience, clinical training, and critical thinking points toward a future where data and story, safety and possibility, can finally grow together.

In this episode of The Vital Point, I'm joined by Kyle Buller: co-founder of Psychedelics Today, breathwork facilitator, and educator specializing in integration and spiritual emergence. Kyle has spent nearly a decade training and teaching in the psychedelic and somatic fields, helping people work skillfully with expanded states.We begin with a grounding guided meditation led by Kyle to help you connect with your body's intelligence - specifically tuning into the awareness of the mind, heart, and gut.From there, we dive into the heart of the conversation: what is spiritual emergence, and how is it different from spiritual emergency? We talk about the risks of destabilization when altered states aren't properly integrated, and why having the right support and frameworks can make all the difference. Kyle breaks down practical ways to recognize where someone is in their process and how to meet them — or yourself — with clarity and care.We also explore Kyle's “GPA” model (Grounding, Processing, Action), the importance of embodiment for facilitators, and why discernment and boundaries are essential for sustainable practice. If you're navigating a period of rapid change — or helping others who are — this conversation offers tools, perspective, and reminders to stay connected to the present moment.The vital point is this: transformation doesn't end at the peak. It begins in how you return.Connect with Kyle at https://www.psychedelicstoday.com/ and InstagramJoin the Blue Magic Alchemy Skool community at https://www.skool.com/bluemagicalchemy

Clinical psychologist Dr. Ros Watts joins Psychedelics Today to share insights from her decade of work with psilocybin therapy and her evolving focus on community-based integration. As the former Clinical Lead for Imperial College London's landmark psilocybin-for-depression trial, Dr. Watts witnessed how psychedelic experiences can foster profound feelings of connection— to self, others, and nature — yet also how that connection can fade without ongoing support. In this conversation, she reflects on what years of research have taught her about connectedness as both a healing mechanism and a human need. She explores how integration work can transform fleeting psychedelic breakthroughs into lasting change, and why community is not just a "nice-to-have," but a core part of psychological and ecological resilience. Dr. Ros Watts also discusses her "Twelve Trees" framework — a nature-inspired model for personal and collective growth that helps participants translate insight into action through values, embodiment, and mutual care. Her current project, ACER Integration (Accept, Connect, Embody, Restore), is a 13-month, co-created journey that guides people in weaving psychedelic insights into everyday life while deepening relationships with self, others, and the living world. Named among the Top 50 Most Influential People in Psychedelics and Top 16 Women Shaping the Future of Psychedelics, Dr. Watts continues to advocate for integration, harm-reduction, and inclusion in the psychedelic space. Together, we explore what sustainable healing really means, how organizations can embody the same principles they teach, and how the psychedelic movement can root itself in care, connection, and community. Learn more about ACER Integration: https://acerintegration.com Find Dr Ros Watt's webpage here. https://www.drrosalindwatts.com/

In this episode, Kyle and Joe sit down with filmmaker Mustapha Khan and Dreamshadow's Elizabeth & Lenny Gibson to explore Life and Breath—a new documentary immersing viewers in the experience and community of Holotropic Breathwork. We talk about why Mustapha was drawn to Dreamshadow, the film's cinéma vérité approach that places you “in the room,” and how years of facilitation informed what became both an archival record and a living portrait of transformation. Elizabeth and Lenny reflect on 35+ years of holding space, the role of curiosity over agenda, and why genuine community—not just catharsis—is central to lasting growth. Kyle and Joe share personal reactions from a Breckenridge screening, the emotions it stirred, and how this work has shaped Psychedelics Today. We close on hope, relationship, and the power of gathering to remember who we are. Keep an eye out for upcoming screenings and Q&As with the team behind Life and Breath. Dreamshadow Life and Breath won first place at the Psychedelic Film and Music Festival!  

This episode gave me goosebumps — and you'll understand why soon.Today, I'm speaking with the identical twin sisters Cipriana Quann and TK Wonder, hosts of the Chew on Something podcast and founders of Urban Bush Babes, a lifestyle platform celebrating the multi-faceted lives of women of color.Cipriana is a former Vogue writer; TK Wonder is a rapper and singer who's opened for artists like Nas and Afrika Bambaataa. Together, they've starred in campaigns for Fendi, Valentino, Tiffany & Co., Sephora, and more.I first saw them years ago in New York City during my Condé Nast days — two striking women shaping culture and fashion. I never imagined that years later, they'd be sitting on The New Health Club podcast couch in Denver with Joe Moore from Psychedelics Today and me, sharing one of the most powerful healing stories I've ever heard.Cipriana and TK open up about surviving sexual, physical, and childhood abuse — and how, for years, they used sugar and comfort food to numb the pain. Their discovery of Ibogaine, a plant medicine known for its deep psychological healing, completely transformed their relationship with their bodies and their health.This is a story about sisterhood, resilience, and the power of psychedelics to help us finally face what we've been running from — and heal for good.In this episode:How trauma shapes our relationship with foodThe healing potential of IbogaineFrom fashion icons to wellness voicesWhat real transformation looks like after trauma✨ How we used food to numb our trauma — and how Ibogaine helped us heal from it.INSTAGRAM@CiprianaQuann@TK-Wonder FOLLOW US ON IG@TheNewHealhInstitute @TheNewHealthClub @philippianne LINKEDIN https://www.linkedin.com/in/annephilippi/ Hosted on Acast. See acast.com/privacy for more information.

Joe and Kyle debrief a hometown Dreamshadow Transpersonal Breathwork weekend in Breckenridge, then sketch the next chapter for Psychedelics Today: a community-centric model (Navigators) that bundles education, live streams, book and film clubs, and small-group access. They kick around the big “creativity + psychedelics” question, contrast subjective “I feel creative” with objective task performance, and highlight new research—from DMT's potential in stroke recovery to breathwork's measurable effects. They wrap with quick hits on MAPS leadership, state policy moves, and what's coming up at PT this fall. Highlights & takeaways Breathwork > substance? A reminder that profound states are accessible without drugs; benefits of facilitating at home (rested facilitators = safer, better containers). What is “shamanism,” really? A functional frame: non-ordinary states, interaction with the unseen, and service (healing/divination). Community > one-off courses: PT is shifting toward a monthly membership model to keep prices accessible, deepen relationships, and sustain more free content. Creativity debate: Double-blind study (DMT + harmine vs harmine vs placebo) suggests impaired convergent thinking despite increased felt creativity; how to define and measure “creativity” fairly, and other research outcomes might tell a different story. Whitehead & novelty: A quick tour through Alfred North Whitehead's notion of “creativity” as the principle of novelty—useful language for mapping psychedelic insight to real-world change. Neuro + clinical frontiers: DMT for stroke (animal models): BBB stabilization and reduced neuroinflammation signal a promising adjunct to current care. Cluster headaches: Emerging reports on short-acting DMT for rapidly aborting cluster cycles; more data coming soon. Breathwork science: New imaging work associates music-supported hyperventilatory breathwork with blissful affect and shifts in blood flow. News & culture mentioned MAPS leadership: Betty Aldworth & Ismail (Izzy) Ali named permanent Co-Executive Directors. Policy snapshots: Colorado Natural Medicine Board recommending ibogaine (with Nagoya-compliance requirement); Alaska signature gathering; Massachusetts activity. Media & scene: Hamilton's recent appearances; contamination concerns in some “psilocybin” products; “psychedelics tick far more neurons than expected” paper; mixed findings for postpartum depression.

In this episode of Psychedelics Today, Joe Moore sits down with Dr. Cat Meyer, licensed psychotherapist, sex therapist, and host of Sex, Love, Psychedelics. Together, they explore the deep intersections of sexuality, trauma healing, psychedelics, and the role of play in human connection. Dr. Meyer shares her journey from growing up in rural Missouri and navigating early trauma to becoming a leading voice in sex therapy and psychedelic integration. She opens up about her personal healing path, her work with ketamine-assisted therapy, and how tantra, BDSM, and art have shaped her approach to erotic wellness. Topics Covered Defining the Erotic: Beyond sex, eroticism as vibrancy, life force, and connection to the senses. Personal Story: Dr. Meyer's early struggles, academic path in marriage and family therapy, and her discovery of tantra and BDSM as transformative practices. Psychedelics and Healing: Her first experiences with MDMA-assisted therapy, ketamine retreats for women, and how these tools can reconnect people with pleasure and embodiment. The Power of Play: Why play is essential for healing, relationships, and cultural transformation—ranging from improv and art to Burning Man experiments. Navigating Power Dynamics: How erotic transference, facilitation, and unconscious needs can shape therapy, sex, and psychedelic work—and why self-awareness is crucial. Feral Mysticism: Rewilding the body, reclaiming personal authority, and embracing vibrancy outside of cultural repression. Pleasure and Illness: How Dr. Meyer works with clients facing chronic pain, fatigue, or illness to maintain erotic connection through presence and small practices. Key Quotes “Eroticism is the connection to vibrancy, to life—it's how we engage with the world through pleasure.” “Feeling is power. A discerning human who can feel is a powerful human.” “Psychedelics help us come back into right relationship with our body and with pleasure.” “Play gives us the freedom to experiment, to try, to be vulnerable, and to learn without attaching our worth to the outcome.”  

In this episode of Psychedelics Today, Joe Moore sits down with Chad Charles — educator, mentor, and practitioner specializing in 5-MeO-DMT therapy. Chad shares his decade-long journey working with 5-MeO-DMT, emphasizing the importance of: Practitioner training and mentorship Personalized, therapeutic alliances The nuanced understanding of dissociative states Ethics in standardized clinical dosing A trauma-informed approach to psychedelic care He also introduces his upcoming research project, analyzing 500+ one-on-one sessions to illuminate best practices and ethical frameworks in the 5-MeO-DMT space. This is a must-listen for anyone passionate about harm reduction, responsible facilitation, and the future of psychedelic therapy.

In this episode of Psychedelics Today, Joe Moore sits down with Alan Davis, Associate Professor at Ohio State University, to explore the evolving landscape of Ibogaine research and its therapeutic potential. Alan offers a deep dive into the Iboga Patient Survey, a groundbreaking initiative collecting real-world data on the safety and efficacy of Ibogaine—particularly for those struggling with substance use disorders and mental health challenges. The conversation sheds light on the need for rigorous, community-informed research that could pave the way toward FDA approval and increased access for patients, including veterans dealing with trauma. They also discuss the complexities of clinical trials, the tension between state and federal regulations, and the growing influence of corporate interests in psychedelic research. Alan emphasizes the importance of ethical transparency, community collaboration, and maintaining scientific integrity as the field grows. If you're curious about the intersection of psychedelic medicine, clinical research, and patient safety, this is a must-listen episode. Topics Covered 00:00 – Introduction and Guest Welcome 00:53 – Reflecting on COVID-19's Psychological Impact 01:29 – Introducing the Iboga Patient Survey 01:46 – History and Goals of Ibogaine Research 02:41 – Challenges in Conducting Clinical Trials 03:14 – Importance of Real-World Safety Data 06:55 – Personal Interest in Ibogaine 08:56 – Veterans and Trauma: A Personal Connection 10:53 – Reintegration and Emotional Processing 15:29 – Survey Participation and Accessibility 18:25 – Building Partnerships and Overcoming Challenges 21:06 – Ensuring Safety and Transparency 31:49 – Community and Academic Collaboration 33:06 – Survey Design and Future Research Directions 36:50 – Momentum in Psychedelic Research 37:48 – State vs. Federal Regulation 39:23 – Challenges in Psychedelic Treatment 43:01 – Corporate Interests and Scientific Objectivity 47:20 – Ketamine and Collaborative Research 51:56 – Ibogaine Patient Survey 57:55 – Psychedelics and Pain Research 01:07:22 – Conclusion and Future Directions

In this engaging episode of the Psychedelics Today podcast, host Joe Moore sits down with Karina Bashir, an attorney working at the intersection of law, business ethics, and psychedelics. Karina, of counsel with Antithesis Law and an active member of the psychedelic community, shares her unique journey from human rights advocacy into the evolving field of psychedelic law. The conversation explores her presentation at Harvard on psychedelics and monotheistic religions, and her efforts to bridge the gap between Islamic communities and psychedelic-assisted healing. She discusses the legal frameworks she navigates to support clients in the psychedelic ecosystem, the spiritual depth of Sufism, and the expansive tradition of Islamic philosophy and mysticism. If you're intrigued by the intersections of religion, law, and psychedelic healing, this episode offers deep insights and hopeful perspectives.

This is the third special episode I recorded in collaboration with Joe Moore from Psychedelics Today at the largest conference in the field "Psychedelic Science 2025" in Denver last week. It very early in the morning, at 8am, and it was fabulous. Our guests in this episode are the hilarious comedian Dennis Walker, the energetic Co-founder (with Myriam Barthes) and CEO of Journey Clinical Jonathan Sabbagh, Philip Drechsel, my Co-Founder of The New Health Institute, and Tom Feegel, Co-Founder of the ibogaine clinic Beond (with Talia Eisenberg) Joe and I talk about the language of healing and how we communicate this to others, when we need to change all together. As Philip shared his healing story with ibogaine, it became clear what a healing opportunity we could experience here. FOLLOW ON IG:The@mycopreneurofficial @jonathansabbagh @beyond.us @thenewhealthinstitute @thenewhealthclub @psychedelicstoday Hosted on Acast. See acast.com/privacy for more information.

In this deeply important episode of Psychedelics Today, Joe Moore is joined by Kristen Nash, MPH, and returning guest Erica Siegel, LCSW, for a nuanced conversation about risk reduction, harm prevention, and ethical education in the psychedelic space. Kristen shares the powerful and heartbreaking story of losing her 21-year-old son after a tragic psychedelic-related incident. Motivated by this loss and her background in public health, she founded the Coalition for Psychedelic Safety and Education and launched the Before You Trip campaign—an educational initiative piloting in Colorado aimed at helping Gen Z users assess their readiness and safety before engaging with psychedelics. Erica contributes her extensive experience from Nest Harm Reduction and Shine Collective, emphasizing the need for peer-based support, non-abstinence frameworks, and trauma-informed approaches. She highlights common pitfalls such as untrained facilitators, predatory behavior, and the pervasive issue of gaslighting in psychedelic communities. Together, they explore the gaps in current education efforts, the dangers of glorifying substances without context, and the moral injuries that can occur when people are harmed or dismissed by the very communities meant to support them. The conversation calls for broader public funding, lived-experience-informed leadership, and transparency around psychological and relational risks—not just physiological harm. The episode also touches on poly-substance use, the limitations of existing drug harm scales, and the importance of setting, support, and intention. With a shared commitment to saving lives and empowering users, Kristen and Erica offer actionable insights and heartfelt reflections on making this space safer for everyone. Listeners are encouraged to follow and support both Before You Trip and Shine Collective to help expand harm reduction education and survivor advocacy.

In this expansive episode of Psychedelics Today, Joe Moore sits down with author and cultural theorist Daniel Pinchbeck to explore the evolving—and increasingly contested—role of psychedelics in society. From the hopeful spirit of transformation that animated earlier psychedelic movements to the sobering reality of biotech, branding, and political entanglement, Daniel offers a candid diagnosis of where we are—and where we might be headed. Reflecting on Psychedelic Science 2025, Daniel discusses the event's stark shift toward commercialization and industry influence. He contrasts this with his earlier work on Evolver, a movement that sought to integrate psychedelics with permaculture, alternative economics, and cultural awakening. Together, Joe and Daniel examine how the field's idealistic origins have been increasingly subjected to capitalist co-option. They also dive into deeper philosophical terrain—discussing monistic idealism, Rudolf Steiner, and the suppression of mystical and paranormal dimensions in the push to medicalize and sanitize psychedelics for mainstream acceptance. Daniel warns of the dangers of ignoring the shadow, including psychic fragmentation and what he calls "entity attachment" from ungrounded use. The conversation ranges from tech billionaires on ketamine to the geopolitical threat of authoritarianism, the weaponization of AI, and the quiet complicity of many in the psychedelic space who avoid political engagement. Daniel shares his current projects, including his Substack newsletter and a new seminar, Breaking the AI Barrier. This is a timely, unflinching exploration of psychedelics as both medicine and mirror—revealing the best and worst of our collective intentions. Can we reclaim the visionary potential of these tools from the grip of capital and control?

This is a special episode I recorded in collaboration with Joe Moore from Psychedelics Today at the largest conference in the field "Psychedelic Science 2025" in Denver last week. It very early in the morning, at 8am, and it was fabulous. Our guests: Daniel Goldberg Co-Founder and Partner at Palo Santo & Bridge Investments & Zac Kamenetz, Founder of Shefa: Jewish Psychedelic Support, Joe and me were talking about the interactions of psychedelic community, the new role of Venture Capital in 2025 and what psychedelic systems are built in the current climate to support individuals and the bigger picture. Check out this episode, it's fun and very insightful.Check out:https://www.shefaflow.org/https://palosanto.vc/ Hosted on Acast. See acast.com/privacy for more information.

This is a special episode I recorded in collaboration with Joe Moore from Psychedelics Today at the largest conference in the field "Psychedelic Science 2025" in Denver last week. It very early in the morning, at 8am, and it was fabulous. Our guests: Tommaso Barba, Neuroscientist from Imperial College London and Dee Dee Goldpaugh, therapist, author and clinical consultant, me and Joe were talking about Sex, Intimacy and Psychedelics! Check out this episode, it's fun and very insightful.IG: @Tommaso.barba @deedeegoldpaugh @psychedelicstoday Hosted on Acast. See acast.com/privacy for more information.

n this episode of Psychedelics Today, kicking of Psychedelic Science 2025 week in Denver, we sit down with Jonathan Dicksinson, Chief Executive Officer, and Trevor Millar, Chief Operations Officer of Ambio Life Sciences – one of the world's leading ibogaine clinics – to explore the potential of ibogaine for addiction, neuroregeneration, and how ethics, honoring experience, and sustainability will be key to delivering ibogaine at scale.  Trevor shares his early work supporting marginalized populations in Vancouver's Downtown Eastside, which led to the founding of Liberty Root, one of Canada's first ibogaine clinics. Jonathan reflects on his apprenticeship in Mexican clinics, years of international advocacy with the Global Ibogaine Therapy Alliance, and drafting the first set of clinical guidelines for ibogaine detoxification. Together with paramedic and ibogaine safety protocols expert Jose Inzunza, they co-founded Ambio in Tijuana in 2021. They discuss: The unique safety standards Ambio has pioneered – including industry-wide clinical protocols and magnesium therapy to mitigate cardiac risk. Their scale: over 3,000 patients treated, with 100+ clients per month across five dedicated houses in Baja California. Ambio's groundbreaking neuroregenerative program for Parkinson's, MS, and traumatic brain injury – which has already drawn patients like Brett Favre and Clay Walker. How ibogaine appears to drive profound physiological change – including evidence of TBI reversal as shown in Stanford's 2024 study on Special Forces veterans. Why ibogaine isn't just a molecule – it opens a long-lasting “critical period” of neuroplasticity that must be supported with preparation, integration, and holistic care. The deeper story of sourcing: through his company Terragnosis, Jonathan is the only person with a legal export license for Tabernanthe iboga from Gabon, and Ambio is setting a precedent for reciprocal and ethical global supply chains. Their cautionary perspective on Texas' $50M push toward ibogaine clinical trials – and why the traditional “one drug, one indication” model misses the complexity and promise of psychedelic healing. They also make a compelling case that Ambio is already modeling what the future of psychedelic care should look like – not a single drug in a sterile clinical setting, but a comprehensive, integrated protocol combining preparation, medical oversight, and deep integration. “Start with the end in mind,” Trevor urges – Ambio isn't just part of the movement; it's the blueprint for how ibogaine could be delivered worldwide. Links: Ambio Website: https://ambio.life/ Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis (Frontiers in Immunology, Feb 2025) Magnesium–ibogaine therapy in veterans with traumatic brain injuries (Nature Medicine, Jan 2024) Ibogaine reduced severe neuropathic pain associated with a case of brachial plexus nerve root avulsion (Frontiers in Pain Research, Aug 2023) Novel treatment of opioid use disorder using ibogaine and iboga in two adults (Journal of Psychedelic Studies, Jan 2020) Clinical Guidelines for Ibogaine-Assisted Detoxification Ambio Life Sciences Launches World's First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions Bios:  Jonathan Dickinson is the Chief Executive Officer and Co-Founder of Ambio Life Sciences. One of the world's leading experts on ibogaine, Jonathan brings over 15 years of experience in clinical care, traditional practice, and psychedelic research to his leadership at Ambio. A Mexico-licensed psychologist and former Executive Director of the Global Ibogaine Therapy Alliance, he authored the field's foundational safety guidelines and has published widely on ibogaine's therapeutic, cultural, and ecological significance. He holds the only active export license for Tabernanthe iboga root, led the first Nagoya-compliant export from Gabon, and was initiated into the Dissoumba/Fang tradition of Bwiti in 2014 and the Missoko tradition in 2022. He has co-authored peer-reviewed research on ibogaine's potential for trauma, TBI, pain, MS, and Parkinson's. At Ambio, he leads strategy, research, and innovation – advancing a globally scalable model of care that bridges tradition, science, and integrity. Trevor Millar is the Chief Operating Officer and Co-Founder of Ambio Life Sciences. A social entrepreneur and pioneer in ibogaine advocacy and treatment, Trevor brings over a decade of experience supporting individuals through addiction recovery, trauma healing, and post-treatment integration. His background includes co-founding the Canadian Psychedelic Association and serving as Chair of the Board for MAPS Canada. He has co-authored peer-reviewed research on ibogaine's applications for trauma, TBI, and opioid use disorder, and has been featured in award-winning documentaries including DOSED and In Waves and War. Grounded in personal experience and guided by a philosophical approach to healing, Trevor is helping shape a new model for ethical, integrative psychedelic care on a global scale. At Ambio, Trevor leads operations, strategic partnerships, and client experience – bridging clinical care with systems design, education, and public advocacy.

In this episode of Psychedelics Today, hosts sit down with Jeff Breau from Harvard Divinity School's Center for the Study of World Religions. Key themes include the intersection of psychedelics and religion, harm reduction practices, and the burgeoning psychedelic church movement. Jeff brings insights from his ethnographic research on psychedelic churches and discusses the importance of interdisciplinary collaboration for advancing understanding in this field. He also delves into the role of music in psychedelic therapy, critiques of the Mystical Experience Questionnaire (MEQ), and the potential for psychedelic chaplaincy. Tune in for an enlightening conversation on the evolving landscape of psychedelics in society and spirituality.   00:00 Introduction and Welcome 00:18 Music in Psychedelic Therapy 02:13 Cultural Context of Music in Therapy 06:08 Personal Journey into Psychedelics and Religion 08:40 Living at an Ashram and Spiritual Practices 15:52 Mystical Experience Questionnaire (MEQ) 33:01 Psychedelic Churches and Legal Challenges 46:11 The Intersection of Law and Religion 46:34 Emergence of Psychedelic Churches 48:41 The Democratization of Mystical Experiences 49:49 Technologies of Revelation 51:10 Novel Rituals and Spiritual Practices 53:49 Humor and Irreverence in Religion 56:44 Reevaluating the Term 'Cult' 01:10:11 Psychedelic Chaplaincy and Spiritual Care 01:18:44 Burning Man as a Model for Religiosity 01:22:43 The Rise of Iboga in American Christianity 01:25:56 Conclusion and Future Directions Links https://cswr.hds.harvard.edu/people/jeffrey-breau

In this episode of Psychedelics Today, Joe Moore speaks with Dr. Simon Ruffell, a London-based psychiatrist, researcher, and curandero-in-training in the López Mahua lineage of the Shipibo tradition. Dr. Ruffell shares how his early fascination with psychiatry eventually led to a deep disillusionment with the limitations of conventional treatments—and a surprising pivot toward the Amazon. Now working at the intersection of Indigenous healing and clinical research, Ruffell describes his journey from medical school to shamanic apprenticeship. He offers insight into the Shipibo understanding of illness across three planes—spiritual, psychological, and physical—and how these ideas challenge Western frameworks. The conversation explores critical questions about the psychedelic renaissance: Are current clinical models missing the energetic and spiritual dimensions of healing? What are the risks of poorly held psychedelic sessions, and how can Indigenous knowledge guide safer practices? Dr. Ruffell advocates for deep training, cross-cultural respect, and collaborative models—such as pairing Indigenous healers with psychiatrists in clinical settings. He also discusses his work with Onaya Science and Onaya.io, organizations that partner with Indigenous communities to study the effects of ayahuasca, particularly in treating PTSD among military veterans. Early findings from their five-year study show that 84% of participants no longer meet PTSD criteria six months after retreat—a promising signal for integrative approaches. This episode offers a rare look at how science and spirituality can coexist. Whether you're a clinician, researcher, or someone seeking deeper healing, Dr. Ruffell's story invites us to question our assumptions and expand our understanding of what true medicine can be.

In this special panel, Joe Moore of Psychedelics Today is joined by Sandor Iron Rope, Lakota spiritual leader and peyote practitioner, and Zach Leary, writer and advocate for psychedelic culture. Together, they explore the critical importance of respecting the cultural, spiritual, and ecological roots of plant medicines. Sandor shares powerful reflections on the Lakota worldview, the trauma of colonization, and the deep spiritual kinship indigenous peoples hold with medicinal plants. Zach reflects on the American counterculture's relationship with psychedelics, highlighting the need to preserve mysticism and community over commercialization. The panel dives into challenges around synthetic versus natural medicines, the risks of spiritual harm when practices are rushed or disconnected from tradition, and the urgent need for indigenous voices at the table as psychedelic policy evolves. Throughout, a theme emerges: slow down, honor kinship, and build right relationship with nature, culture, and spirit. This conversation offers a rare and necessary bridge between indigenous wisdom and the psychedelic resurgence, calling for respect, collaboration, and a return to deep roots to guide future generations. Learn more at ipci.life and psychedelicstoday.com.

On today's episode of Best Book Ever, Rabbi David Kasher is joined by Madison Margolin to talk about psychedelic experiences in the Torah. Madison is the author of Exile & Ecstasy: Growing Up with Ram Dass and Coming of Age in the Jewish Psychedelic Underground. She's also Co-founder of the Jewish Psychedelic Summit and DoubleBlind, a print magazine and digital media startup covering psychedelics and where they intersect with mental health, environmental justice, social equity, and more, Madison also teaches on Judaism and psychedelics, such as with Tzfat's LiveKabbalah or Psychedelics Today, and offers consulting and guidance for those on the Jewish-psychedelic path.

On today's episode, Rabbi David Kasher is joined by Madison Margolin to talk about psychedelic experiences in the Torah. Madison is the author of Exile & Ecstasy: Growing Up with Ram Dass and Coming of Age in the Jewish Psychedelic Underground. She's also Co-founder of the Jewish Psychedelic Summit and DoubleBlind, a print magazine and digital media startup covering psychedelics and where they intersect with mental health, environmental justice, social equity, and more, Madison also teaches on Judaism and psychedelics, such as with Tzfat's LiveKabbalah or Psychedelics Today, and offers consulting and guidance for those on the Jewish-psychedelic path.

In this episode, Kyle Buller speaks with Kayse Geheret, founder of Microdosing for Healing and instructor for Psychedelics Today's Vital program. They explore what it means to be a modern guide in the world of psychedelics. Kayse shares how microdosing has become a key entry point for many and highlights the importance of training, community, and personal growth. They discuss how not all psychedelic work involves facilitation. Some guides support through integration, education, or community organizing. The conversation covers what makes a great guide—qualities like groundedness, empathy, curiosity, and the ability to hold space. They also talk about the growing need for psychedelic-literate professionals in all fields, not just therapy. Kayse and Kyle reflect on the importance of finding the right training—whether for coaching, integration, or peer support. With more people entering the space, education and connection are more important than ever. Whether you're curious about microdosing, thinking of becoming a guide, or simply want to better support your community, this episode offers valuable insight.

In this episode of Psychedelics Today, Joe Moore sits down with South African ethnobotanist and healer Jean-François Sobiecki to explore the rich and largely underrecognized world of African psychoactive plants. With over two decades of fieldwork and research, Jean-François sheds light on the traditional use of these plants in healing, divination, and spiritual practices across Southern Africa. Topics covered include: Jean-François's early inspirations and the ancestral roots of his herbal knowledge His discovery and documentation of 306 African psychoactive plant species The ritual use of Ubuwalu (dream-enhancing emetic infusions) and their role in personal transformation How vomiting, dietary restrictions, and sensory isolation are used as part of initiation processes Cross-cultural parallels between Southern African and Amazonian plant healing traditions The underexplored use of psychoactive plants to treat mental health conditions like schizophrenia and hysteria Ethical fieldwork, indigenous knowledge protection, and the dangers of overharvesting sacred plants Visions for healing and conservation gardens in Africa and the role these plants could play in global mental health Jean-François shares moving stories of his 15-year mentorship with a Northern Sotho diviner and healer, Letti Ponnya, and how she introduced him to African “plant teacher” medicines. His message is clear: Africa has a deep, sophisticated, and scientifically underappreciated tradition of psychoactive plant use that deserves recognition, respect, and further study.

In this episode of Psychedelics Today, Kyle Buller is joined by Dr. Hannah McLane, founder of the SoundMind Center and SoundMind Institute. They dive deep into the evolving psychedelic landscape—touching on policy developments in New Jersey, Massachusetts, Pennsylvania, and beyond. Dr. McLane shares her experience testifying in support of psilocybin legislation and discusses the medical frameworks being explored, particularly in contrast to Oregon and Colorado's models. The conversation also explores the essential qualities of effective psychedelic facilitators, emphasizing the importance of self-awareness, lifelong learning, and doing personal inner work. Dr. McLane offers insights into the challenges of entrepreneurship in the psychedelic space, balancing mission-driven work with sustainability, and how neurodiversity and trauma have shaped her approach. Toward the end, the conversation takes a playful and heartfelt turn, reflecting on parenting, the power of curiosity, and the need for more community-centered, human-first spaces for integration and healing. This is a rich, honest, and inspiring dialogue that bridges the personal and political, the clinical and ceremonial, and the visionary future of psychedelics.

In this powerful episode of Psychedelics Today, we sit down with the team behind Natural Medicine Alaska to discuss their groundbreaking efforts to bring psychedelic reform to the state. With some of the highest rates of depression, suicide, and substance use disorders in the nation, Alaska stands at a pivotal moment in the movement for mental health transformation. Joe Moore speaks with Gina, President of Natural Medicine Alaska; David Aloff, an Alaska Native advocate; and Noria Clark, Veterans Coordinator to explore the origins of their movement, the importance of traditional healing protections, and their 2026 ballot initiative to decriminalize plant medicines and establish a regulated therapeutic model. The discussion dives into: The personal journeys that led each guest to this work How Alaska's libertarian spirit aligns with psychedelic reform The push to make Alaska the first state to include Ibogaine clinics in legislation The urgent need for veteran and first responder access to psychedelic therapy Fundraising and grassroots efforts to get the initiative on the ballot The role of Alaska's natural landscape in healing and psychedelic integration With national psychedelic policy at a crossroads, Alaska has the opportunity to become the North Star of this movement. Listen in to learn how you can support this critical campaign! Support Natural Medicine Alaska:

Podcast Show Notes: Psychedelics, Harm Reduction & Ethical Care with Erica Siegal In this episode of Psychedelics Today, Joe Moore sits down with Erica Siegal, founder of Nest Harm Reduction and Shine Collective, for a deep conversation on psychedelic harm reduction, ethical facilitation, and the evolving psychedelic landscape. Erica shares her journey from the Grateful Dead lot scene to festival harm reduction, social work, and leading initiatives to support survivors of psychedelic-related harm. The conversation covers: Erica's background in hospitality, social work, and psychedelic harm reduction The mission of Nest Harm Reduction in offering psychedelic therapy, integration, and community education The work of Shine Collective, a nonprofit supporting survivors of psychedelic harm and abuse The challenges of ethical facilitation, power dynamics, and the importance of clear boundaries How the psychedelic community can better address harm, accountability, and survivor support The intersection of Jewish spiritual traditions and psychedelics through Shefa This episode is a must-listen for those passionate about harm reduction, ethical psychedelic practice, and building a safer, more accountable psychedelic culture.

Army Ranger to consultant to leading one of the most respected psychedelic retreat organizations, detailing how meditation and psychedelic therapy helped him heal from trauma. The conversation covers: Neal's military background and his path to psychedelics The mission and structure of Beckley Retreats, an offshoot of the Beckley Foundation How their retreats integrate meditation, preparation, and integration for long-lasting benefits The legal landscape of psilocybin in Jamaica and the Netherlands Challenges and lessons from running a psychedelic retreat business The future of psychedelics, from global access to potential federal policy shifts Whether you're curious about immersive psychedelic retreats, the intersection of mental health and psychedelics, or the evolving legal landscape, this episode is packed with insight. Learn more about Beckley Retreats here. Hear more from Neil on Psychedelics Today here.

In this episode, Joe Moore of Psychedelics Today sits down with Paul Austin, founder of The Third Wave, to dive deep into the evolution of microdosing and its growing role in psychedelic culture. Paul shares how his journey with microdosing LSD led him to launch The Third Wave in 2015 to make psychedelics more accessible through education. The conversation explores the latest research on microdosing, including clinical trials demonstrating its potential benefits for depression, mental clarity, and creativity. Paul and Joe discuss the nuances of different microdosing protocols, the role of psychedelics in performance optimization, and the impact of these substances on neuroplasticity. They also tackle key challenges, such as the lack of robust clinical research due to regulatory hurdles and the perceived risks associated with overuse. Beyond microdosing, they touch on the broader psychedelic landscape—regulatory shifts, emerging coaching models, and the future of psychedelic-assisted transformation. The discussion even ventures into intriguing intersections between psychedelics, AI, and the possibility of extraterrestrial intelligence. Tune in for a thought-provoking conversation on where microdosing fits into the larger psychedelic resurgence.

In this episode of Psychedelics Today, Joe Moore sits down with Louis Dorian, the visionary behind Psychedelist, a groundbreaking global platform designed to support the emerging psychedelic movement. Described as a “cyber city” for all things psychedelic, Psychedelist connects individuals with treatment providers, educators, facilitators, legal experts, and even vetted product vendors in an effort to enhance accessibility and safety in this evolving space. Louis shares his journey into psychedelics, from early rave days to a transformative encounter with high-dose LSD and psilocybin that shaped his worldview. He opens up about the struggles of navigating trauma, loss, and the shortcomings of Western psychiatric care, leading him to develop his own trauma-processing techniques blending meditation, breathwork, and psychedelics. The conversation also dives deep into the broader implications of drug prohibition, harm reduction, and the role of skill-building in responsible psychedelic use. Whether you're a seeker, a skeptic, or a professional in the field, this episode offers a compelling exploration of the psychedelic landscape and the power of intentional community building. Resources: Visit Psychedelist Follow Louis Dorian on Instagram: @psychedelist More from Psychedelics Today: Website Tune in for an eye-opening discussion on the future of psychedelics, regulation, and self-exploration!

In this episode of Psychedelics Today, Joe Moore is joined by Neeka Levy and Zach Skiles of Heal Ukraine Trauma, a nonprofit bringing psychedelic-assisted therapy to veterans and civilians affected by war. They discuss the organization's origins, the impact of intergenerational trauma in Ukraine, and the evolving role of psychedelic treatments in a war-torn nation. Nika, a first-generation Ukrainian-American and neuroscience-trained psychiatric nurse practitioner, and Zach, a Marine veteran turned psychologist, share their journey into this work, highlighting the importance of group ketamine therapy as a scalable, culturally aligned solution. They explore Ukraine's complex regulatory landscape, the need for rigorous research, and the challenges of working in a war zone. They also touch on the role of psychedelics in processing moral injury, the importance of including family members in healing, and how Ukraine's collectivist culture influences therapeutic approaches. With insights on historical trauma, ethical considerations, and the potential future of MDMA and psilocybin therapy in Ukraine, this conversation sheds light on a vital, evolving effort.

A poetically epic journey, from the porosity we're born with, to walking a nonlinear path and growing toward honoring our callings while staying grounded and present. We discuss and invite an incorporation of science with spiritual and earth-based wisdom. We reflect on what we've been learning and receiving from our feminine friendship, reflecting on the concept of "sistering" as a verb. Jasmine Virdi (she/her) is a writer, educator, poet, and activist based between Cyprus and Mexico. Her writing centers on psychedelics, spirituality, and deep ecology and has been featured in DoubleBlind Magazine, Open Democracy, Science and Non-Duality, and Psychedelics Today. Jasmine has an MSc in Transpersonal Psychology and offers private coaching and mentorship to clients. She is an advocate for decolonising healing practices, and integrates earth-based wisdom, trauma-informed approaches and somatics into her work. Follow Jasmine's Substack - Foraged Wisdom - a monthly newsletter that gathers and collects insights on world-building amidst systems collapse, weaving together animism, earth-based spirituality, grief work, decolonisation, magic, and the richness of the human spirit.

In this episode, Kyle interviews Tommy Aceto: former Navy Seal and trauma medic, and now, ambassador for the Veteran Mental Health Leadership Coalition and advisor at Beond Ibogaine. He talks about how much the psychedelic space focuses on healing and mental health, but doesn't talk enough about the overall wellness that can come from a consistent practice: that the more you become aware of your body, emotions, and breath, the more robust your neural pathways will become – and that you can actually change your neurochemistry and build a more energetically powerful system. With these pathways being opened, fewer psychedelic experiences are necessary, and with practice, these mind states can be achieved simply through meditation or breathwork. The idea of surrender and entering a state of receivership is scary, but he believes the most important skill to begin that transformation is to learn how to truly let go. He also talks about: What the psychedelic scene is like in Nashville and the south His work with the Kentucky Opioid Abatement Advisory Commission and what happened with the bill to grant 42 million for ibogaine research His most powerful 5-MeO-DMT experience and how it reconnected him with the divine The science and practice of gratitude: how reframing painful experiences can actually rewire the brain How cold exposure (notably ice baths) can prepare your system for a psychedelic experience and more! Happy New Year from all of us at Psychedelics Today. Let's hope for big psychedelic wins in 2025! For links, head to the show notes page.

Many of us experience ego death through psychedelics, but what happens when someone actually dies and returns to share their insights? Kyle Buller, co-founder of Psychedelics Today, had his life transformed at 16 after a traumatic snowboarding accident left him with a profound near-death experience (NDE). In this episode, Kyle shares his journey from navigating his NDE to exploring altered states of consciousness through psychedelics, transpersonal psychology, and Holotropic Breathwork.Kyle and Lana discuss how these extraordinary states can catalyze personal transformation, the critical importance of integration, and why taking time to slow down is essential for practitioners and explorers alike. In the meat of this conversation, they also explore the concept of spiritual emergence, a phenomenon where transformative experiences can lead to personal crises or growth, and how to navigate the fine line between awakening and overwhelm. Together, they examine the responsibility of psychedelic work and the need for cultural frameworks to support those undergoing these profound shifts.Topics Covered:Gaps in the psychedelic education spaceSupporting individuals through different phases of psychedelic workWhy bother having an expanded state of consciousnessHow to make the most out of challenging psychedelic experiencesPumping the breaks on transformational work and grounding into the everydayHow Kyles NDE at age 16 changes his perspective on life and deathSpiritual emergence and emergency: when mystical experiences create crisisCommon symptoms, challenges and experiences during a spiritual emergenceEgo Inflation as Spiritual EmergencyAdvocates of psychedelics need to be honest about the challengesKyle's deeply destabilizing experience with LSD (depersonalization & derealization)Sponsors:Natural Shilajit10% off with LANA10OFFKanna Wellness10% off with LANAShow Links:Vital Psychedelic Training: Learn more herePsychedelics Today Podcast: Visit hereBooks: Spiritual Emergency: When Personal Transformation Becomes a Crisis and The Stormy Search for the Self by Stanislav and Christina GrofSpiritual Emergence as Ego Inflation (Jules Evans article about Sowilo Retreats)

Psychedelics Then and Now with Zach Leary: Episode 01 - East Forest: Music for Mushrooms This is the first episode in the rebranded Psychedelics Then and Now Podcast with Zach Leary. Formerly the MAPS Podcast - the show will continue to bring you insightful and entertaining interviews with some of the great minds within the psychedelic community. The podcast is a collaboration between Zach Leary and Psychedelics Today.  We relaunch with an all new episode featuring East Forest, a multidisciplinary artist, producer, and ceremony guide. Since 2008, East Forest's “lush” (Rolling Stone) and “blissful” (NPR) music has blended ambient, neoclassical, electronic, and avant-pop to explore sound as a tool for inner journeys and consciousness expansion. The project's latest endeavor is the feature-length film Music for Mushrooms, a narrative documentary showcasing the transformative power of psychedelics, music, and community. The accompanying Official Documentary Soundtrack is an immersive album featuring tracks recorded during live psilocybin ceremonies. East Forest's extensive catalog includes over 30 albums and notable collaborations with artists such as Ram Dass, Jon Hopkins, Laraaji, Dead Prez, Nick Mulvey, Peter Broderick, Max Cooper, and DJ ANNA. The project has performed in over 18 countries at major festivals and venues including BottleRock, Beyond The Pale, Mysteryland, Wilderness and SXSW.

Support the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USBuy Grow kit: https://modernmushroomcultivation.com/

In this episode, Kyle interviews Mustapha Khan: Emmy Award-winning director with over 100 film and television credits, who has worked with clients such as Coca-Cola and Honda, and celebrities ranging from Maya Angelou to Snoop Dogg. Khan is finalizing a film about Lenny and Elizabeth Gibson and their ongoing work at Dreamshadow – the people and community responsible for Joe and Kyle meeting and the creation of Psychedelics Today. He talks about meeting the Gibsons, being welcomed into their community (instead of his proposed “fly on the wall” role), how centered and happy he felt after his first breathwork session, and what he has learned through the process: that breathwork can be an incredibly healing modality, but the magic he has found has been more in the community surrounding it, and the responsibility (and honor) of being a sitter for someone else. He discusses: The first time his breathwork went psychedelic, and speaking with his recently deceased Mothe How he got into filmmaking and why he wants to tell stories about people like the Gibson The beauty of breathwork not having a dogma or doctrine attached to it The power in holding space for someone else, even if it's just being presen The importance of taking action that aligns with psychedelic ethos: What can you do to contribute to your community? and more!  Khan is hoping to release the documentary, “Life and Breath,” in October. In addition to a screening at Dreamshadow, PT will likely do a virtual one as well, so stay tuned for updates! For links, head to the show notes page.

In this conversation, Joe Moore, co-founder and CEO of Psychedelics Today, discusses the evolution and impact of the psychedelics movement from both individual and societal perspectives. Joe shares his background in the field, leading into the broad-reaching work of Psychedelics Today in education, media, and events since its inception in 2016.The discussion explores the importance of creating safe cultural containers for psychedelic experiences and their potential for addressing global crises. The conversation emphasizes the intertwined roles of individual transformation and societal change, advocating for ending the drug war and improving public education to integrate these substances meaningfully and safely into society.Additionally, the conversation touches on the structure and goals of the VITAL training program, aiming to provide a comprehensive and diverse education for those with a professional interest in psychedelics. The overarching message underscores the power of individual actions combined with collective efforts to foster a better world.Topics Covered:The journey of building a world-leading psychedelic education platform since 2016What it means to be “anti-drug war”Creating safe cultural containers for psychedelic usageWhat it will take for society at large to accept psychedelicsHow psychedelics can be used to combat greater social and environmental issuesSeeing through the illusions to heal society at largeThe balance between individual and social healingWhat is really happening in the psychedelic underground?A look into Vital: Psychedelics Today's comprehensive training for psychedelic professionalsShow Links:Apply for 1:1 Coaching with LanaVital Psychedelic TrainingWhere to find Joe:IG: @psychedelicstodayTwitter: @psychedelicstodayFacebook, Youtube, LinkedIn: Psychedelics Today Website: https://psychedelicstoday.com/Vital: https://www.vitalpsychedelictraining.com/ Want more Modern Psychedelics?Instagram | YouTube | Web | Facebook Inspired to transform your life from the inside out, and integrate higher consciousness in your day to day life?Explore 1:1 Coaching with Lana or Apply Now Please support the show: leave a review on Apple or a 5-star rating on Spotify if this episode sparked something within. FREEBIES to support your journey DISCLAIMER: Modern Psychedelics does not endorse or support the illegal consumption of any substances. This show is meant for entertainment purposes only. Modern Psychedelics does not sell or promote the sale of any illegal substances. The thoughts, views and opinions on this show should not be taken as life advice, medicinal advice, or therapeutic guidance.

In this episode of the Psychedelic Medicine Podcast, podcast host Dr. Lynn Marie Morski comes on the mic to provide a five-year update on the podcast and share the changes in the legal landscape of psychedelics in the past half-decade. Lynn Marie Morski, MD, JD is the president of the Psychedelic Medicine Association and host of the Psychedelic Medicine Podcast. She sits on the advisory boards of Psychedelics Today, Cybin, VETS, Inc (Veterans Exploring Treatment Solutions), the Oxenberg Foundation, and the Ketamine Task Force. Dr. Morski is a Mayo Clinic-trained physician in family medicine and sports medicine, as well as an attorney and former adjunct law professor. In this anniversary episode you'll hear about the legally-accessible forms of psychedelic therapy which have come to prominence as potential mainstream therapeutics in recent years. Dr. Mroski shares Information on the legal adult use framework for psilocybin in Oregon, including licensing, costs, and exclusion criteria. She also discusses programs in Australia and Canada that will allow certain patients to access psychedelic therapies such as psilocybin- and MDMA-assisted therapy. In addition to classic psychedelic medicines, Dr. Morski also shares information on the medicine which is currently most accessible: ketamine. She discusses the difference between S-ketamine and R-ketamine and on-label and off-label uses of this substance. In closing, Dr. Morski presents some of the finer details of the current landscape of insurance coverage for ketamine.    In this episode you'll hear: The difference between decriminalization and legalization The FDA decision to deny the Lykos Therapeutics' new drug application for MDMA-assisted therapy for PTSD The upcoming Colorado psilocybin program Psychiatric licenses to administer MDMA and LSD to patients in Australia  The Special Access Program for psychedelic therapies in Canada  Legal ketamine access in the United States How the Psychedelic Medicine Podcast chooses guests   Quotes: “I wanted to focus mostly on what is legal because we know that's the way things are going to be the most monitored and therefore safely accessible.” [20:45] “People are in this industry because they want other people to feel better and they want to help and they're so generous with their time” [25:31]   Links: clinicaltrials.gov - the place to find information on upcoming clinical trials for psychedelic medicine for which you may qualify Insurance Coverage for Psychedelic Therapy by Vincent Joralemon SPRAVATO withMe Patient Support Program Enthea insurance Previous episode: How to Choose A Psychedelic Facilitator or Retreat Center with Joël Brierre Previous episode: Warning Signs When Selecting a Psychedelic Facilitator with Juliana Mulligan Previous episode: Ketamine Scientific Research with Dr. Jason Wallach Psychedelic Medicine Association Porangui

Are you curious about the transformative power of psychedelics and how they are reshaping mental health and wellness? In this episode, we are joined by Joe Moore and Kyle Buller, co-founders of Psychedelics Today. With over 20 years of experience, Joe is an expert in transpersonal breathwork and drug policy, while Kyle specializes in psychedelic integration and mental health counseling. Together, they discuss their global platform, which is at the forefront of psychedelic education, media, and advocacy. You'll learn about the latest developments in the field and the multidisciplinary approach that bridges scientific, philosophical, and cultural perspectives.You can find show notes, resources and more at: https://tinyurl.com/3a7wkvwn 

This week we chat about micro dosing and the potential benefits of it...C.J. Spotswood, MSN, APRN, PMHNP aka “EntheoNurse” is a board certified psychiatric-mental health nurse practioner working in an emergency department in central Maine. C.J. is a 3rd generation male nurse and has 20 years of psychiatric nursing experience. C.J. has been researching and teaching on psychedelics since 2018, which include having presented at the American Psychiatric Nurse Association's National Conference on psychedelics in psychiatry, teaching master classes for Psychedelics Today's Navigating Psychedelics: Clinicians & Therapists education program, co-authored Psychedelic.Support's continuing education module on psilocybin, and is a past presenter at the Mt. Tam's Psilocybin Summit.C.J. is the author of “The Microdosing Guidebook: A Step-by-Step Manual to Improve Your Physical and Mental Health through Psychedelic Medicine” which will be available through Ulysses Press on March 8th, 2022. C.J. presents an accredited continuing education program entitled “Psychedelics in Psychiatry for Nurses” on his personal website. C.J. is a charter member of the International Association of Psychedelic Nurses, member of the Psychedelic Medicine Association, and the American Psychiatric Nurse Association. Resources: “The Microdosing Guidebook: A Step-by-Step Manual to Improve Your Physical and Mental Health through Psychedelic Medicine”FacebookXIGKeywords: Medicine| Psychedelics| Microdosing| Guidebook| Mental Health| Health| florafungapodcast| podcast| Nurse| Medical| Entheonurse| Healing| benefits| ConferenceZbiotics: "FLORA10"Drink ZBiotics before drinking alcohol-Alcohol produces acetaldehyde, a byproduct that your next daySupport the Show.***I am an affiliate with ENERGYBITS (your daily algae tablet packed with nutrients) go visit this link and use code FLORAFUNGA at checkout for 20% off***Get 20% off Sovereignty use code "KK20" Zbiotics: "FLORA10"Drink ZBiotics before drinking alcohol-Alcohol produces acetaldehyde, a byproduct that your next day SUPPORT THE SHOW: Join my Patreon for only $1/month [THATS only .03 cents a day!]Follow my other social media sites to interact and engage with me:Email me to be on the podcast or inperson Interview: floraandfungapodcast@gmail.com FacebookInstagramTwitterTikTokYouTubePatreonNew audio done by Reflect--go show him some support!-Spotify...

Jo Shuman is a mental health nurse, in the field for 30 years. She has worked in several settings: Community Mental Health Clinics; Substance Abuse Programs; a State Prison; and has spent the last 10 years working for the Ulster County Mobile Mental Health Team. She just completed  a year long program through Psychedelics Today called Vital: Psychedelic Therapies and Integration. She has been a volunteer for the Restorative Justice 180 Program for 10 years and marvels at the growth she has witnessed in the youth it serves. She is a life long activist and has experienced the power of civil disobedience and getting into good trouble. She is also a proud mother of four in a blended family and grandmother of 8.Today we get to learn about Jo and her beautiful life, from fighting back against racist behavior in junior high, to protecting the land and humans from uranium mining and the danger in the transport of nuclear weapons, she's been a long time activist who is really lead by her heart in all she does. We learn about her work and why she's taken on such impactful roles, what she's learned about humans and relating with others, and how we can better take care of ourselves and others. Our conversation goes philosophically deep into many of the issues that Jo has been involved with in her work, and she shares her insight eloquently. If you'd like to connect with Jo as a resource in any of the subjects she discussed, please reach out and I will connect you. You can also find her on Instagram.She's beginning a monthly gathering for folks who have had a psychedelic or non-ordinary state experience in conjunction with the O+ Festival on July 9th. RSVP if you'd like to be a part of it.Today's show was engineered by Ian Seda from Radiokingston.org.Our show music is from Shana Falana!Feel free to email me, say hello: she@iwantwhatshehas.org** Please: SUBSCRIBE to the pod and leave a REVIEW wherever you are listening, it helps other users FIND IThttp://iwantwhatshehas.org/podcastITUNES | SPOTIFYITUNES: https://itunes.apple.com/us/podcast/i-want-what-she-has/id1451648361?mt=2SPOTIFY:https://open.spotify.com/show/77pmJwS2q9vTywz7Uhiyff?si=G2eYCjLjT3KltgdfA6XXCAFollow:INSTAGRAM * https://www.instagram.com/iwantwhatshehaspodcast/FACEBOOK * https://www.facebook.com/iwantwhatshehaspodcast

Joe Moore co-founded Psychedelics Today in 2016 with Kyle Buller. As CEO, Joe has co-created one of the planet's best-known psychedelic podcasts and training platforms. He combines over 20 years of avid psychedelic study and training with over 20 years of experience in software and multinational project management. Joe is a leading expert in transpersonal […]

Dr. Ido Cohen, Psy.D - serves individuals, couples, and groups in San Francisco. He received his Psy.D from the California Institute of Integral Studies and trained at the Jung Institute In San Francisco. He works with a diverse range of challenges childhood trauma, inner critic, relationship and intimacy challenges, lack of fulfillment, psychospiritual growth as well as psychedelic integration and preparation sessions with individuals and groups. His doctoral study researched the integration process of Ayahuasca ceremonies while applying Jungian psychology to better understand how to support individuals in their process of change and transformation. He is currently finishing a study on the use of psychedelics in couples. He is the founder of “The Integration Circle” and facilitates workshops on the different dimensions of integration and the intersection of mental health, spiritual health, and the entheogenic experience. Ido also teaches with "Psychedelics Today" and is the resident integration facilitator for Doubleblind magazine. Ido is passionate about supporting individuals to create long-term, sustainable change leading to intimate, authentic, expressive, and love-filled lives. In his free time, he likes to find new paths in nature with his dog Luna, marvel at art, write, create, and connect with his community.Episode Highlights▶Dr. Ido Cohen's background and work in psychedelics▶Deep dive into Ayahuasca experiences and integration▶The importance and challenges of integration in psychedelic therapy▶The complexities of accessibility and ethics in psychedelic facilitation▶The complex relationship between money, ethics, and psychedelics▶The challenges of integration and accountabilityDr. Ido Cohen's Links & Resources▶ Email: idocohen.therapy@gmail.com▶ Instagram: http://instagram.com/dr.idocohen▶ Instagram: https://www.instagram.com/theintegrationcircle/  Download Beth's free business trainings here: Integrating Psychedelics & Sacred Medicines Into a Transformational Business:https://bethaweinstein.com/psychedelics-in-businessClarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business https://bethaweinstein.com/grow-your-spiritual-business ▶ Beth's Programs & Courses: https://bethaweinstein.com/services▶ Beth on Instagram: http://instagram.com/bethaweinstein▶ Beth Weinstein on Facebook: https://www.facebook.com/bethw.nychttps://www.facebook.com/BethWeinsteinbiz▶ Join the free Psychedelics & Purpose Community: https://www.facebook.com/groups/PsychedelicsandSacredMedicines

Episode 74 - Joe Moore, Psychedelics Today Joe Moore, CEO and co-founder of Psychedelics Today, joins this episode of the MAPS podcast for a wide ranging discussion around the past, present and future of psychedelic culture. Joe shares some of his personal story, the origins of Psychedelics Today, feelings around the War on Drugs and take home ketamine. Joe has so much in depth knowledge on the current state of psychedelic growth, culture and harm reduction. His take is not to be missed.  Joe Moore is CEO and co-founder of Psychedelics Today.  Psychedelics Today is the planetary leader in psychedelic education, media and advocacy. Psychedelics are set to disrupt the way humanity approaches healing and wellness, making way for a new paradigm in healthcare and cognitive liberty. We bridge scientific, academic, philosophical, societal, and cultural disciplines, covering up-to-the-minute developments and diving deep into crucial topics. Together, we are leading the discussion in this rapidly evolving ecosystem. Through compelling content, thoughtful conversation and industry-leading education for a community of over 2.2 million annual learners, Psychedelics Today has the largest global reach of any media platform in the modern psychedelic realm. We honor this responsibility with humanity and humility.

The riveting Rebecca Martinez in a conversation about her new book, Whole Medicine! In this episode you will hear about the natural world as central in the conversation about people, plant medicine, ethics and expanded states; Alma Institute; being on both sides of the altar; power, harm and responsibility; normalizing conflict; a wish for this book to educate and empower the psychedelic naive; shrinking the power dynamics between facilitators and journeyers; and a pondering of, how are the medicines doing? Finally, Rebecca reads an excerpt from Whole Medicine for us. I highly recommend the book! Link to purchase in the show notes. Rebecca Martinez is a Chicana parent, writer, community organizer, and social entrepreneur living in Portland, Oregon. She is the Founder and Executive Director of Alma Institute, a nonprofit educational institution that equips trainees from marginalized communities to become legal psilocybin facilitators. She is also the author of Whole Medicine: A Guide to Ethics for Psychedelic Therapy and Plant Medicine Communities, published by North Atlantic Books in 2024. She is a voice on psychedelic justice and has been featured in NPR, Business Insider, STAT News, Lucid News, and Psychedelics Today. Links: Order Whole Medicine Alma Institute Rebecca's Website Rebecca's Instagram https://www.psychedelicsafetyflags.com/

In this episode, Joe speaks with Paul F. Austin: Founder & CEO of Third Wave, Founder of Psychedelic Coaching Institute, and host of Third Wave's The Psychedelic Podcast. Recorded in-person at this year's reMind conference, this episode – a shared release with Third Wave – is a rare glimpse into the inner workings of both Psychedelics Today and Third Wave, with Joe and Paul reconnecting after early podcast appearances and interviewing each other about where they've come from and where they're going now that they're so many years into this. Paul breaks down Third Wave's history and new coaching training program, and Joe discusses Vital: Why he invested in Vital over an investment raise, what we've learned from the first two cohorts, how we've handled scholarships, and why sometimes losing money can be worth it if it's for the greater good. They talk about the challenge of keeping the lights on while trying to create something new; the balance of running a media company while building out an educational platform; the importance of staying focused and ignoring the noise; the relationship-building they've seen from their students; why we need to welcome the corporate types we may be inclined to dismiss; and why seeding good actors in as many roles and communities as possible is vital to the growth of psychedelics.  Click here to head to the show notes page. 

In this illuminating episode of The Psychedelic Podcast, host Paul F. Austin engages in a thought-provoking conversation with Joe Moore, the CEO of Psychedelics Today. For a full summary and show links, go here: https://thethirdwave.co/podcast/episode-229-joe-moore/ Recorded in-person at the 2023 reMind conference in Las Vegas, this conversation delves into the profound lessons and insights gained from navigating the unique challenges of the psychedelic space. Paul and Joe unpack the often-overlooked necessity of incorporating best business practices into psychedelic companies and explore the critical components of effective psychedelic training or coaching programs. Join Paul and Joe as they break down their respective programs—the Psychedelic Coaching Institute's Coaching Certification Program and Vital Psychedelic Training—and compare the content and approach of each. Together, Paul and Joe share their hard-earned lessons from running psychedelic businesses, discuss the pros and cons of relying on investments in the psychedelic space, and ponder the potential future of the psychedelic landscape amidst legal shifts and evolving healthcare models. This conversation provides an insightful and balanced exploration into the heart of the psychedelic renaissance. Joe Moore: Joe Moore co-founded Psychedelics Today in 2016 with his business partner Kyle Buller. As CEO, Joe has created one of the world's best known psychedelic podcasts, blogs and training platforms. Joe combines more than twenty years of avid research and training in psychedelics with twenty years of experience in software and multinational project management. Joe has led countless transpersonal breathwork workshops and is a much sought-after international speaker on the intersecting subjects of psychedelic medicine and healing, breathwork, drug policy, medical innovation, international justice and environmentalism. Highlights: Joe and Paul's journeys starting businesses early on in the latest psychedelic renaissance. The pros and cons of relying on investments in the psychedelic space. Paul unpacks The Psychedelic Coaching Institute's Coaching Certification Program. Joe shares the origin and evolution of Vital Psychedelic Training. How Vital approaches Scholarships. Joe and Paul's hard-earned lessons from running psychedelic businesses. Considering decrim, access, legalization, and healthcare models for psychedelics. How to learn more about the programs by Third Wave and Psychedelics Today.   Key Links: Psychedelics Today: https://psychedelicstoday.com    Vital Psychedelic Training: https://www.vitalpsychedelictraining.com    Psychedelics Today on Instagram: https://www.instagram.com/psychedelicstoday/    Vital Psychedelic Training on Instagram: https://www.instagram.com/vitalpsychedelic/    Episode Sponsors: Joyous microdose ketamine The Coaching Certification Program by Third Wave's Psychedelic Coaching Institute.

In this episode, we toast to the beginning of an exciting and hopefully groundbreaking 2024 by switching things up a bit. Christopher Koddermann, Co-Founder and Chair of Board of the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI) will be conducting some interviews for PT, and in this episode, he does his first – with our Co-Founders, Joe Moore and Kyle Buller. Kyle tells the story of his fateful New Years Eve snowboarding trip that resulted in a near death experience and a complete change in his life's trajectory, and Joe discusses his more academic roots and how he and Kyle were united through their shared passion for the work of Stan Grof, holotropic breathwork, and transpersonal psychology. Psychedelics Today was created largely with no aims other than to promote transpersonal psychology and archive the best insights from their mentors, but has obviously turned into so much more, mostly from the simple goal of trying to spread the word through interesting conversations. They talk about the growth of PT; how they got involved in education; the harms of the drug war; why decriminalization isn't enough; where they see ‘the psychedelic renaissance' going; what has surprised them the most in the last few years; and what we're most proud of: Vital – how it came to be created, what's involved, the benefits of the retreats, the self-discovery they've witnessed, and what they've learned through two successful cohorts. The next edition of Vital begins on January 23, and we've extended applications until January 14, so if you've been curious if Vital is the answer you've been looking for, now is the time to act! Click here to head to the show notes page.